NR
NurExone Biologic Inc.
NRXBF · OTC
$0.45 +6.84% (+$0.03)
1M +38.37%
Valuation
-
N/A P/B N/A
EV/FFO N/A
P/E N/A
Growth
-
N/A Book val. growth N/A
FCF growth N/A
EPS growth N/A
Profitability
-
N/A FCF margin N/A
Op. margin N/A
Gross margin N/A
Quality
-
N/A Asset turnover N/A
ROA N/A
ROIC N/A
Debt
-
N/A Net debt/EBITDA N/A
Int. coverage N/A
Debt/Equity N/A
Stability
47 /100
Moderate Beta 0.39x
EPS volatility N/A
Profitable years N/A
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o NRXBF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Lior Shaltiel
Employees
16
Headquarters
Toronto
Prihajajoči dogodki
25 NOV.
Earnings
Upcoming earnings report